The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity.
about
MLL5 (KMT2E): structure, function, and clinical relevance.A Novel Sterol-Signaling Pathway Governs Azole Antifungal Drug Resistance and Hypoxic Gene Repression in Saccharomyces cerevisiae.Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.miR-126-5p promotes retinal endothelial cell survival through SetD5 regulation in neurons.
P2860
The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Human Mixed Lineage Leukem ...... Intrinsic Catalytic Activity.
@ast
The Human Mixed Lineage Leukem ...... Intrinsic Catalytic Activity.
@en
type
label
The Human Mixed Lineage Leukem ...... Intrinsic Catalytic Activity.
@ast
The Human Mixed Lineage Leukem ...... Intrinsic Catalytic Activity.
@en
prefLabel
The Human Mixed Lineage Leukem ...... Intrinsic Catalytic Activity.
@ast
The Human Mixed Lineage Leukem ...... Intrinsic Catalytic Activity.
@en
P2093
P2860
P50
P1433
P1476
The Human Mixed Lineage Leukem ...... o Intrinsic Catalytic Activity
@en
P2093
Andrey Lebedev
Catherine Teyssier
Christian Dumas
Louise E Bird
Sarah Mas-Y-Mas
P2860
P304
P356
10.1371/JOURNAL.PONE.0165139
P407
P50
P577
2016-11-03T00:00:00Z